| |
| |
|
| Insider
Information: |
Dolsten Mikael |
| Relationship: |
Director |
| City: |
Madison |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
327,440 |
|
|
Indirect Shares
|
1,981 |
|
|
| Direct
Value |
$10,396,219 |
|
|
|
Indirect Value
|
$58,638 |
|
|
| Total
Shares |
329,421 |
|
|
| Total
Value |
$10,454,857 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -16.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pfizer Inc |
PFE |
President R&D |
2024-02-28 |
321,729 |
2024-02-28 |
1,981 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
5,711 |
2021-09-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| A |
Agilent Technologies Inc |
Director |
• • – |
2024-03-15 |
4 |
A |
$147.48 |
$247,471 |
D/D |
1,678 |
5,711 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2024-02-28 |
4 |
D |
$27.04 |
$579,656 |
D/D |
(21,437) |
321,729 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2024-02-23 |
4 |
D |
$27.76 |
$689,059 |
D/D |
(24,822) |
343,166 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
– • – |
2023-03-16 |
4 |
A |
$136.82 |
$226,848 |
D/D |
1,658 |
4,018 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2023-02-25 |
4 |
D |
$41.75 |
$1,548,007 |
D/D |
(37,078) |
354,145 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2023-02-22 |
4 |
D |
$42.38 |
$1,381,249 |
D/D |
(32,592) |
391,223 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2022-11-07 |
4 |
OE |
$30.17 |
$2,627,260 |
D/D |
79,108 |
420,007 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2022-05-11 |
4 |
S |
$49.31 |
$3,151,547 |
D/D |
(63,902) |
333,342 |
0 |
% |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2022-03-17 |
4 |
A |
$136.82 |
$244,224 |
D/D |
1,785 |
2,352 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2022-03-03 |
4 |
OE |
$27.34 |
$3,261,036 |
D/D |
102,460 |
396,578 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2022-02-26 |
4 |
D |
$47.72 |
$1,419,384 |
D/D |
(29,744) |
294,118 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2022-02-23 |
4 |
D |
$46.87 |
$1,395,179 |
D/D |
(29,767) |
323,862 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-12-17 |
4 |
OE |
$30.17 |
$2,147,712 |
D/D |
71,187 |
351,637 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-11-11 |
4 |
S |
$50.28 |
$3,000,647 |
D/D |
(59,664) |
279,842 |
0 |
% |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-11-11 |
4 |
OE |
$22.89 |
$5,014,926 |
D/D |
199,548 |
339,506 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2021-09-22 |
4 |
A |
$172.44 |
$97,773 |
D/D |
567 |
567 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-02-27 |
4 |
D |
$33.49 |
$798,435 |
D/D |
(23,841) |
137,727 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-02-25 |
4/A |
D |
$33.82 |
$956,125 |
D/D |
(28,271) |
161,568 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-02-25 |
4 |
D |
$33.82 |
$956,125 |
D/D |
(28,271) |
156,568 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2020-05-18 |
4 |
S |
$37.75 |
$3,602,681 |
D/D |
(95,353) |
174,918 |
0 |
% |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2020-02-28 |
4 |
D |
$33.42 |
$1,318,285 |
D/D |
(39,446) |
268,515 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2020-02-26 |
4 |
D |
$34.72 |
$1,312,138 |
D/D |
(37,792) |
307,961 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
45,566 |
345,753 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2019-03-04 |
4 |
S |
$43.52 |
$2,136,293 |
D/D |
(49,082) |
289,126 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2019-03-01 |
4 |
S |
$43.56 |
$4,376,852 |
D/D |
(100,471) |
338,208 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
